EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Psychiatric and neurological manifestations in adults with Smith–Magenis syndrome: A scoping review

Dorinde Korteling iD, Jiska L I Musch iD, Janneke R Zinkstok iD, Erik Boot iD

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2024

DOI: 10.1002/ajmg.b.32956 ↗

Kurz gefasst

Scoping Review in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2024. Verfasst von Dorinde Korteling und 3 weiteren Autor:innen. Beteiligte Einrichtung: Child and Adolescent Psychiatry & Psychosocial Care, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Smith-Magenis Syndrome, Intellectual Disability, Neurodevelopmental Disorders. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Smith–Magenis syndrome (SMS) is a neurodevelopmental disorder caused by a 17p11.2 deletion or a pathogenic variant of the RAI1 gene, which lies within the 17p11.2 region. Various psychiatric and neurological disorders have been reported in SMS, with most literature focusing on children and adolescents. To provide an overview of the current knowledge on this topic in adults with SMS, we performed a comprehensive scoping review of the relevant literature. Our findings suggest that many manifestations that are common in childhood persist into adulthood. Neuropsychiatric manifestations in adults with SMS include intellectual disability, autism spectrum‐ and attention deficit hyperactivity disorder‐related features, self‐injurious and physical aggressive behaviors, sleep–wake disorders, and seizures. Findings of this review may facilitate optimization of management strategies in adults with SMS, and may guide future studies exploring late‐onset psychiatric and neurological comorbidities in SMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smith-Magenis SyndromeIntellectual DisabilityNeurodevelopmental DisordersAdultChildAdolescentHumansTrans-ActivatorsAggression

Stichwörter der Autor:innen

17p11.2RAI1Smith-Magenis syndromeadultneurologypsychiatry

Substanzen

Trans-Activators

Autor:innen und Institutionen

  • Child and Adolescent Psychiatry & Psychosocial Care, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Utrecht University, Utrecht, The Netherlands.
  • Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Karakter Child and Adolescent Psychiatry, Nijmegen, The Netherlands.
  • Department of Psychiatry and Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Advisium, 's Heeren Loo, Amersfoort, The Netherlands.

ORCID-Profile: Dorinde Korteling, Jiska L I Musch, Janneke R Zinkstok, Erik Boot

Zitieren

APA

Korteling, D., Musch, J. L. I., Zinkstok, J. R., & Boot, E. (2024). Psychiatric and neurological manifestations in adults with Smith–Magenis syndrome: A scoping review. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.32956

Vancouver

Korteling D, Musch JLI, Zinkstok JR, Boot E. Psychiatric and neurological manifestations in adults with Smith–Magenis syndrome: A scoping review. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2024. doi:10.1002/ajmg.b.32956

BibTeX
@article{Korteling2024,
  author = {Korteling, Dorinde and Musch, Jiska L I and Zinkstok, Janneke R and Boot, Erik},
  title = {Psychiatric and neurological manifestations in adults with Smith–Magenis syndrome: A scoping review},
  journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
  year = {2024},
  doi = {10.1002/ajmg.b.32956}
}
Kostenlos starten →